CARPALL: Immunotherapy with CD19+CD22 CAR T-cells for CD19+ and CD22+ Acute Lymphoblastic Leukaemia

NCT02443831 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia

Interventions

PROCEDURE: Leukapheresis
RADIATION: Total Body Irradiation (TBI)
DRUG: Lymphodepletion with Fludarabine
DRUG: Lymphodepletion with Cyclophosphamide
BIOLOGICAL: CD19+CD22 CAR T-cells

Sponsor

University College, London